Seventh Annual International Umbilical Cord Blood Transplantation Symposium, Los Angeles, California, June 5-6, 2009

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 1, 2010, Pages 12-27

  Wagner, John E ^a   Laughlin, Mary ^b   Petz, Lawrence ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c StemCyte   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; FM 140; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LITHIUM; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARATHYROID HORMONE; PLACEBO; STEROID; TACROLIMUS; THIOTEPA; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADVANCED CANCER; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANALYTIC METHOD; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD TRANSFUSION; CANCER MORTALITY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG MEGADOSE; EDITORIAL; EMBRYONIC STEM CELL; ENGRAFTMENT; GRAFT INFECTION; GRAFT VERSUS HOST REACTION; HLA MATCHING; HODGKIN DISEASE; HUMAN; IMMUNOBIOLOGY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL EDUCATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; NONHUMAN; NONMYELOABLATIVE CONDITIONING; OVERALL SURVIVAL; PLURIPOTENT STEM CELL; REDUCED INTENSITY CONDITIONING; SALVAGE THERAPY; SINGLE DRUG DOSE; SPINAL CORD INJURY; SURVIVAL RATE; SURVIVAL TIME; T LYMPHOCYTE; TREATMENT FAILURE; UNITED STATES; WHOLE BODY RADIATION;

BLOOD BANKS; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR SELECTION; FETAL BLOOD; GRAFT VS HOST DISEASE; HUMANS; INFECTION; REGENERATIVE MEDICINE; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 72649103904     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.08.023     Document Type: Editorial

References (0)